NIGMS

Confronting TB resistance

Vanderbilt researchers describe how certain tuberculosis treatments work and suggest these medications may overcome the threat of drug-resistant tuberculosis.

HIV virus

A “public” target for HIV

Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus.

3d rendering white blood cells with red blood cells

Putting the brakes on sepsis

An enzyme called PTEN reduces inflammatory signaling and mortality in sepsis, suggesting it may be a good therapeutic target for this life-threatening complication of infection.

Toxin floats on lipid rafts

The bacterium H. pylori is a leading cause of stomach cancer, and Vanderbilt researchers are studying how one of its toxins gets into cells.

How the skin protects

Treatments for common skin conditions such as atopic dermatitis may be improved by understanding the enzymes responsible for forming the skin’s water-tight barrier.

New view of the heartbeat

Structural views of the proteins that regulate the heartbeat may help improve existing treatments for cardiac arrhythmias.

1 8 9 10 11 12 22